We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01618292
First Posted: June 13, 2012
Last Update Posted: January 28, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Jennifer Pagnillo, Atlantic Health System
  Purpose
Compare changes in bowel function before, 6 months and one year after Robotic-assisted laparoscopic sacral colpopexy. Compare objective anatomic outcomes before, 6 months and one year after Robotic-assisted laparoscopic sacral colpopexy.

Condition Intervention
Pelvic Organ Prolapse Constipation Bowel Dysfunction Irritable Bowel Syndrome Procedure: Robotic sacral colpopexy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy

Resource links provided by NLM:


Further study details as provided by Jennifer Pagnillo, Atlantic Health System:

Primary Outcome Measures:
  • Changes in bowel function [ Time Frame: preoperatively, 6 months, and one year post-surgery ]
    -Patients completed a validated colo-rectal-anal distress inventory (CARDI-8) at all 3 intervals. Specific complaints of splinting with defecation, excessive straining/pain with bowel movements, incomplete bowel emptying/obstructive symptoms and fecal incontinence were addressed. In addition, patients completed a validated colorectal-anal impact questionnaire (CRAIQ-7) at all 3 intervals. The CRAIQ-7 addresses bowel symptoms and the extend of quality of life impingement


Secondary Outcome Measures:
  • Objective anatomic outcomes [ Time Frame: preoperatively, 6 months, and one year after surgery ]
    The pelvic organ prolapse quantification system (POP-Q)- an objective, validated, standardized method of quantifying the degree of pelvic organ prolapse present was used at all visits.


Enrollment: 393
Study Start Date: January 2007
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Robotic-assisted sacrocolpopexy patients
Patients who underwent robotic-assisted laparoscopic sacrocolpopexy between January 2007 and August 2011.
Procedure: Robotic sacral colpopexy
Patients who underwent robotic assisted sacral colpopexy for the treatment of pelvic organ prolapse
Other Name: robotic-assisted laparoscopic sacral colpopexy

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women suffering from pelvic organ prolapse who underwent a robotic assisted laparoscopic sacral colpopexy between January 2007 and August 2011.
Criteria

Inclusion Criteria:

  • All patients who underwent robotic assisted laparoscopic sacral colpopexy

Exclusion Criteria:

  • Any other procedure for the treatment of pelvic organ prolapse
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01618292


Locations
United States, New Jersey
Atlantic Health System
Morristown, New Jersey, United States, 07960
Sponsors and Collaborators
Atlantic Health System
Investigators
Principal Investigator: Patrick Culligan, MD Atlantic Health System
  More Information

Responsible Party: Jennifer Pagnillo, Patrick Culligan, MD, Atlantic Health System
ClinicalTrials.gov Identifier: NCT01618292     History of Changes
Other Study ID Numbers: R11-08-011
First Submitted: June 11, 2012
First Posted: June 13, 2012
Last Update Posted: January 28, 2014
Last Verified: January 2014

Keywords provided by Jennifer Pagnillo, Atlantic Health System:
pelvic organ prolapse
constipation
bowel dysfunction
irritable bowel syndrome (IBS)
CRADI-8
CRAIQ-7
splinting with defecation
excessive straining
bowel movements
fecal incontinence
bowel symptoms

Additional relevant MeSH terms:
Constipation
Irritable Bowel Syndrome
Prolapse
Pelvic Organ Prolapse
Intestinal Diseases
Gastrointestinal Diseases
Signs and Symptoms, Digestive
Signs and Symptoms
Colonic Diseases, Functional
Colonic Diseases
Digestive System Diseases
Pathological Conditions, Anatomical